Bio Impact Capital LLC I Teos Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $641 Million
- Q3 2024
A detailed history of Bio Impact Capital LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 1,745,943 shares of ITOS stock, worth $14.8 Million. This represents 2.78% of its overall portfolio holdings.
Number of Shares
1,745,943
Previous 1,745,943
-0.0%
Holding current value
$14.8 Million
Previous $25.9 Million
31.2%
% of portfolio
2.78%
Previous 4.16%
Shares
5 transactions
Others Institutions Holding ITOS
# of Institutions
165Shares Held
36.5MCall Options Held
890KPut Options Held
374K-
Black Rock Inc. New York, NY3.73MShares$31.6 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.18MShares$26.9 Million0.45% of portfolio
-
Boxer Capital, LLC San Diego, CA2.95MShares$24.9 Million1.6% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$23.2 Million19.24% of portfolio
-
Tang Capital Management LLC San Diego, CA2.41MShares$20.4 Million2.09% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $301M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...